Oct 11, 2017

The pancreatic and biliary stents market is driven by two methods: endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography. There are four essential pancreatic and biliary stents; the secured metal stents, the in part secured metal stents, the non-secured metal stents, and plastic stents. The market will keep on growing as growth predominance increments and patients turn out to be more acquainted with stenting as a treatment alternative. This report inspects the pancreatic and biliary stents in 21 European markets: Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and the UK.

There are two major players in the pancreatic and biliary stents market with most market share and extensive product line is Boston Scientific and Cook Medical. Other top players in the pancreatic and biliary stents market include Taewoong Medical, ELLA-CS, and EndoFlex.

In 2016, the Global Stents Pancreatic and Biliary Stents market estimated value at $203.6 million and expected to grow at a CAGR of 5.40% to reach a value of $293.9 million.

The market is driven by an expansion in endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) methods, and also an expanded rate in the quantity of these systems requiring stenting and repetitive stenting. The fully covered metal pancreatic and biliary stents market is expanding at the faster rate, while the non-covered metal pancreatic and biliary stents market is decreasing trend globally.

For more industry reports visit MarketsandReports.Com/MarketReports